Seòmar agus comataidhean

The Scottish Government is focused on delivering for people across the country and making the case for taking decisions in Scotland for Scotland with independence.

The Scottish Government will publish further material on independence to give the people of Scotland the information they need to make an informed choice about their constitutional future. We are not planning an independence convention this summer.

The Scottish Government fully recognises the benefits of hedgerows and trees.

The Scottish Government recognises the vital role the livestock sector plays in supporting rural communities. We do not have a policy to reduce livestock numbers and fully recognise the value that livestock plays in Scotland's rural communities, maintaining bio diversity and our food sector. In order to understand what is happening within the sector we are committed to assessing, through engagement with stakeholders, the potential social and economic impacts of any changes in the size of the beef herd - whether driven by market trends, consumer behaviour, or technological change - on rural areas across Scotland.

This assessment will be carried out through ongoing engagement with farmers, crofters, industry representatives and rural stakeholders, alongside analysis of rural economies and land use. In stark contrast to the UK Government we continue to demonstrate our commitment to the beef sector through a range of support schemes, including the Scottish Suckler Beef Support Scheme (SSBSS), which provides targeted, coupled support for livestock producers In addition, the retention of the Basic Payment Scheme (BPS) in Scotland is helping to maintain income stability for many beef producers. This reformed direct support reflects the unique challenges facing our farming and crofting communities and underlines our determination to deliver a sustainable future for rural Scotland.

There are no data gathering or reporting requirements in relation to the number of medicines prescribed off-label, centrally. Health Boards are expected to collect this data as part of their local medicine governance processes.

The £60 million play park renewal funding is allocated to local authorities to use across their whole play estate. It is the responsibility of the individual Local Authorities to manage their own budgets and to allocate the total financial resources available to them based on local needs and priorities. The Scottish Government recognise that the extent of renewal and refurbishment will be influenced by local plans and investment priorities and engagement with children and young people.

As agreed with COSLA at the start of the funding programme in 2021, Local Authorities report annually on the number of renewals undertaken in their area at the end of April. Local Authorities are not required to list details of each renewal or the names or locations of every play park that has been renewed. However, in accordance with the agreed national principles and as per the reporting template agreed with COSLA, renewal work can include introducing new equipment, replacing existing equipment, extra seating, suitable surfaces, toilet facilities, planting, improved access points and circulation routes, water fountains and other suitable measures to make parks more inclusive, welcoming and enjoyable.

The Scottish Government worked with COSLA on the national principles for the play park renewal programme, which is used to guide Local Authorities’ renewal programme. The national principles set out how Local Authorities should review their existing estate, prioritise renewal work, and design play parks that offer improved play opportunities for children and families. The national principles state that access to play should be as wide-reaching and inclusive as possible, ensuring all children have access to play spaces where they feel safe and comfortable to use them.

Guidance to clinicians to support prescribing medicines off-label is provided by the General Medical Council (GMC) . The guidance states that doctors should usually prescribe licensed medicines in accordance with the terms of their licence but they may prescribe medicines off-label where, on the basis of an assessment of the individual patient, they conclude, for medical reasons, that it is necessary to do so to meet the specific needs of the patient. In addition, extant guidance states that, unless there is a specific clinical reason, clinicians should prescribe a licensed medicine which has been accepted for routine use in the NHS in Scotland by the Scottish Medicines Consortium (SMC) as opposed to prescribing off-label or unlicensed medicines.

Funding for the Deal is awarded to the Stirling and Clackmannanshire region rather than individual council areas, including joint projects between the three main Deal partners, Stirling Council, Clackmannanshire Council and University of Stirling. The Stirling and Clackmannanshire City Region Deal private sector investment total secured to date is £476,000, with this investment coming through the University of Stirling’s Scotland’s International Environment Centre (SIEC Phase 1) as commissioned work.

All other secured and leveraged investment in the Deal is from the public sector, including academia, or third sector.

The Finance and Public Administration Committee is currently conducting an inquiry into the cost effectiveness of Scottish Public Inquiries. I wrote to the Committee on 30 May 2025 providing a detailed response to their request for information from Scottish Government in relation to its role as sponsor of current and previous public inquiries. This response noted that Section 17 of the Inquiries Act 2005 confers responsibility for the procedure and conduct of an inquiry on its Chair, independent of Ministers, and that this includes a statutory requirement for a Chair to act 'with regard to the need to avoid any unnecessary cost (whether to public funds or to witnesses or others)'.

Assessment of value for money would therefore be a matter for a Chair of an inquiry to consider as they deem appropriate within the overall duty to avoid unnecessary cost, and those inquiries which are currently ongoing have responded independently to the call for evidence received from the Committee on costs. Responses are published on the Committee pages of the Scottish Parliament website.

The findings and conclusions of the Committee's inquiry will be considered once known.

The following table shows a) the number of Young Persons’ Free Bus Travel Scheme cardholders broken down to local authority level as of 31 May 2025, and b) the number of journeys, broken down by local authority, made through the Young Persons’ Free Bus Travel Scheme since its launch in January 2022 up to 31 May 2025. Journeys are based on the local authority in which the card was issued, therefore some journeys will have been undertaken out with the local authority area.

Patients continue to be seen based on their clinical urgency, and those referred with an urgent suspicion of cancer continue to be prioritised for scope-based diagnostic tests. The decision to appropriately prioritise patients based on their urgency is best placed with the clinicians responsible for their care.

Health boards across NHS Scotland have local strategies in place to ensure patients with a clinical urgency, as well as those that have waited the longest, are investigated within an appropriate time by the most appropriate person. Referrals are clinically triaged at local board level and directed to the most appropriate waiting list.

The Scottish Government expects Health Boards to ensure an investigation is undertaken, and the verified report is received by or made available to the requester, within a 6-week waiting times standard for key diagnostic tests and procedures. Health Boards must take all reasonable steps to ensure they comply with this standard.

We know many people are still waiting too long and this is not good enough. We are determined do more and our Budget will provide a record £21.7 billion for health and social care.

As part of planned care funding for 2025-26 we have provided over £10.5 million to territorial health boards across Scotland to support endoscopy activity and reduce waiting lists.

To specifically support scope based diagnostics we have published an Endoscopy and Urology Diagnostic Recovery and Renewal Plan backed by £70 million. The plan focuses on key areas such as: Balancing Demand and Capacity; Workforce Training and Development; Infrastructure; and Innovation and Redesign.